Abstract:ASK1-JNK signaling promotes mitochondrial dysfunction-mediated apoptosis, but the bridge between JNK and apoptosis is not fully understood. PUMA induces apoptosis through BAX/BAK. Our previous study suggests a therapeutic potential of PUMA for ovarian cancer. However, whether and how PUMA activates ASK1 remains unclear. Here, we found for the first time that PUMA activated ASK1 by dissociating thioredoxin (TRX) from ASK1, however, it neither interacted with ASK1 nor TRX. Furthermore, PUMA overexpression caused ROS release from mitochondrial. H2O2 significantly impaired the interaction of ASK1 with TRX, whereas ROS scavenger NAC effectively abrogated the H2O2 effect, partly rescued PUMA-interfered interaction of ASK1 with TRX, and also abolished ASK1 phosphorylation. Interestingly, PUMA could not impair the association of ASK1 with TRX-C32S or TRX-C35S, two TRX mutants which are no longer oxidized in response to ROS. We further showed that PUMA activated ASK1-JNK axis to phosphorylate BCL-2 and BCL-XL, further augmenting apoptosis of ovarian cancer cells. In vivo, PUMA adenovirus combined with paclitaxel significantly inhibited intrinsically cisplatin-resistant ovarian cancer growth, and caused phosphorylation of BCL-2 and BCL-XL. Our results from human ovarian cancer TMA chips also revealed a positive correlation between PUMA expression and the phosphorylation of BCL-2 and BCL-XL. More importantly, all patients had no distal metastasis, implying a possibly clinical significance. Collectively, our results reveal a new pro-apoptotic signal amplification mechanism for PUMA by which PUMA overexpression first induces ROS-mediated dissociation of TRX from ASK1, and then causes JNK activation-triggering BCL-2/BCL-XL phosphorylation, ultimately augmenting apoptosis in ovarian cancer.

Puma Promotes Bax Activation in A Foxo3a-Dependent Manner in Sts-Induced Apoptosis

PUMA Promotes Bax Translocation in FOXO3a-dependent Pathway During STS-induced Apoptosis

Puma Promotes Bax Translocation by Both Directly Interacting with Bax and by Competitive Binding to Bcl-X-L During Uv-Induced Apoptosis

Puma Overexpression Induces Reactive Oxygen Species Generation And Proteasome-Mediated Stathmin Degradation In Colorectal Cancer Cells

FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal.

PUMA, a potent killer with or without p53

Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.

Regulation Of Transactivation-Independent Proapoptotic Activity Of P53 By Foxo3a

Promoting apoptotic effect of p53 up-regulated modulator of apoptosis

Effects of Exogenous PUMA on Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells

Exogenous P53 Upregulated Modulator of Apoptosis (PUMA) Decreases Growth of Lung Cancer A549 Cells

Promotes Bax Translocation by Competitive Binding to Bcl-Xl During UV Irradiation-Induced Apoptosis

PUMA Overexpression Dissociates Thioredoxin from ASK1 to Activate the JNK/BCL-2/BCL-XL Pathway Augmenting Apoptosis in Ovarian Cancer.

Expression of PUMA in Follicular Granulosa Cells Regulated by FoxO1 Activation During Oxidative Stress.

The BH3-only Protein, PUMA, is Involved in Oxaliplatin-Induced Apoptosis in Colon Cancer Cells

Sp1 is Involved in H2O2-induced PUMA Gene Expression and Apoptosis in Colorectal Cancer Cells

Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells

Regulation of Bax activation and apoptotic response to UV irradiation by p53 transcription-dependent and -independent pathways.

Jnk- And Akt-Mediated Puma Expression In The Apoptosis Of Cisplatin-Resistant Ovarian Cancer Cells

PUMA: a New Target in Cytoprotective and Tumor Therapy

The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells.